Summary: In an interview with Lucid News, MAPS Founder and Executive Director Rick Doblin, Ph.D., explains MAPS’ innovative $70 million regenerative financing structure with Vine Ventures, which is designed to ensure that most MDMA-assisted therapy revenues remain available to fund the mission-driven priorities of MAPS and MAPS Public Benefit Corporation (MAPS PBC).
Doblin honestly acknowledges “a sense of massive failure” for not achieving sustainability through philanthropy alone, and goes on to say that “on the other hand it feels like a success, in that it’s mission aligned people. They’re not going to have a seat on the board, they’re not going to own any stock. They’re not going to really interfere with what we do.”
